Adenovirus-mediated IKKbetaKA expression sensitizes prostate carcinoma cells to TRAIL-induced apoptosis (Q40391803)

20 September 2017

Adenovirus-mediated IKKbetaKA expression sensitizes prostate carcinoma cells to TRAIL-induced apoptosis (English)

1 reference

20 September 2017

0 references

1 reference

1 reference

Sanlioglu AD

1

1 reference

20 September 2017

Koksal IT

2

1 reference

20 September 2017

Karacay B

3

1 reference

20 September 2017

Baykara M

4

1 reference

20 September 2017

Luleci G

5

1 reference

20 September 2017

Sanlioglu S

6

1 reference

20 September 2017

1 January 2006

1 reference

20 September 2017

1 reference

20 September 2017

13

1 reference

20 September 2017

1

1 reference

20 September 2017

21-31

1 reference

https://scigraph.springernature.com/pub.10.1038/sj.cgt.7700877

20 September 2017

0 references

cites work

p53, the cellular gatekeeper for growth and division

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700877

New insights into p53 regulation and gene therapy for cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700877

Clinical significance of p53 functional loss in squamous cell carcinoma of the oropharynx.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700877

Targeting death receptors in cancer with Apo2L/TRAIL.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700877

Synergistic induction of apoptosis in breast cancer cells by cotreatment with butyrate and TNF-alpha, TRAIL, or anti-Fas agonist antibody involves enhancement of death receptors' signaling and requires P21(waf1).

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700877

Increased cytotoxicity of soluble Fas ligand by fusing isoleucine zipper motif

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700877

Apo2 ligand/tumor necrosis factor-related apoptosis-inducing ligand cooperates with chemotherapy to inhibit orthotopic lung tumor growth and improve survival

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700877

Elevated AKT activity protects the prostate cancer cell line LNCaP from TRAIL-induced apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700877

Control of TRAIL-induced apoptosis by a family of signaling and decoy receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700877

Effects of sequential treatments with chemotherapeutic drugs followed by TRAIL on prostate cancer in vitro and in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700877

Doxorubicin pretreatment sensitizes prostate cancer cell lines to TRAIL induced apoptosis which correlates with the loss of c-FLIP expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700877

An antibody against DR4 (TRAIL-R1) in combination with doxorubicin selectively kills malignant but not normal prostate cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700877

Biologic sequelae of nuclear factor-kappaB blockade in multiple myeloma: therapeutic applications

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700877

NF-kappaB inducers upregulate cFLIP, a cycloheximide-sensitive inhibitor of death receptor signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700877

The novel receptor TRAIL-R4 induces NF-kappaB and protects against TRAIL-mediated apoptosis, yet retains an incomplete death domain

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700877

TRAIL receptors 1 (DR4) and 2 (DR5) signal FADD-dependent apoptosis and activate NF-kappaB

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700877

Death receptor 5, a new member of the TNFR family, and DR4 induce FADD-dependent apoptosis and activate the NF-kappaB pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700877

Lipopolysaccharide induces Rac1-dependent reactive oxygen species formation and coordinates tumor necrosis factor-alpha secretion through IKK regulation of NF-kappa B.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700877

Adenoviral-mediated transfer of the TNF-related apoptosis-inducing ligand/Apo-2 ligand gene induces tumor cell apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700877

Cellular redox state alters recombinant adeno-associated virus transduction through tyrosine phosphatase pathways

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700877

Direct gene transfer of human CFTR into human bronchial epithelia of xenografts with E1-deleted adenoviruses.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700877

Inhibition of the NF-kappaB pathway enhances TRAIL-mediated apoptosis in neuroblastoma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700877

Constitutive activation of nuclear factor-kappaB prevents TRAIL-induced apoptosis in renal cancer cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700877

The role of NF-kappa B in TNF-related apoptosis-inducing ligand (TRAIL)-induced apoptosis of melanoma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700877

Fundamental principals of tumor necrosis factor-alpha gene therapy approach and implications for patients with lung carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700877

IkappaBalpha gene transfer is cytotoxic to squamous-cell lung cancer cells and sensitizes them to tumor necrosis factor-alpha-mediated cell death.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700877

Protein kinase B regulates T lymphocyte survival, nuclear factor kappaB activation, and Bcl-X(L) levels in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700877

Gas6 anti-apoptotic signaling requires NF-kappa B activation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700877

Resistance of prostate cancer cells to soluble TNF-related apoptosis-inducing ligand (TRAIL/Apo2L) can be overcome by doxorubicin or adenoviral delivery of full-length TRAIL.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700877

Differential effects of phosphatidylinositol-3/Akt-kinase inhibition on apoptotic sensitization to cytokines in LNCaP and PCc-3 prostate cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700877

Ionizing radiation enhances the therapeutic potential of TRAIL in prostate cancer in vitro and in vivo: Intracellular mechanisms

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700877

Aberrant methylation of trail decoy receptor genes is frequent in multiple tumor types

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700877

Rheumatoid arthritis synovial fluid macrophages express decreased tumor necrosis factor-related apoptosis-inducing ligand R2 and increased decoy receptor tumor necrosis factor-related apoptosis-inducing ligand R3.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700877

An antagonist decoy receptor and a death domain-containing receptor for TRAIL

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700877

TRAIL: a molecule with multiple receptors and control mechanisms

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700877

7 January 2021

Rel/NF-kappaB transcription factors protect against tumor necrosis factor (TNF)-related apoptosis-inducing ligand (TRAIL)-induced apoptosis by up-regulating the TRAIL decoy receptor DcR1

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700877

7 January 2021

Akt protects mouse hepatocytes from TNF-alpha- and Fas-mediated apoptosis through NK-kappa B activation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700877

7 January 2021

Simultaneous inhibition of Rac1 and IKK pathways sensitizes lung cancer cells to TNFalpha-mediated apoptosis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700877

7 January 2021

Phosphatidylinositol 3-kinase and NF-kappa B/Rel are at the divergence of CD40-mediated proliferation and survival pathways

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700877

7 January 2021

Identifiers

DOI

10.1038/SJ.CGT.7700877

1 reference

Dimensions Publication ID

20 September 2017

0 references

1 reference